Literature DB >> 22014055

Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

John R Gosney1, Ian J Williams, Andrew R Dodson, Christopher S Foster.   

Abstract

AIMS: To compare the morphology and antigenic profile of pulmonary neuroendocrine cells (PNECs) proliferating as a reaction to pulmonary injury with those proliferating in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in which carcinoids develop. METHODS AND
RESULTS: The morphology and expression of a range of antigens including markers of epithelial differentiation [cytokeratins, thyroid transcription factor (TTF)-1], neuroendocrine antigens [neural cell adhesion molecule (NCAM), chromogranin, protein gene product (PGP) 9.5, neurone-specific enolase (NSE), synaptophysin], peptide products [gastrin-releasing peptide (GRP), calcitonin, calcitonin gene-related peptide (CGRP)] and inactivator [common acute lymphoblastic leukaemia antigen (CALLA)] and antigens involved in cell proliferation and death (p53, p16, p27, Rb, Bcl-2, c-kit, Ki67) were studied in four cases of reactive PNEC proliferation and seven cases of DIPNECH. Proliferation was more florid in DIPNECH. There was no major shift in antigen expression with proliferation in either group apart from CALLA, which was expressed only by proliferating cells and not by solitary PNECs. There were differences between the groups in expression of p53, p16 and Ki67, which were seen more consistently and earlier in proliferation in DIPNECH.
CONCLUSIONS: These data suggest that there are early and fundamental differences in cell kinetics between the reactive PNEC proliferation that occurs in response to pulmonary injury and that seen in the pre-neoplastic condition of DIPNECH. 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014055     DOI: 10.1111/j.1365-2559.2011.03992.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

Review 1.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

2.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.

Authors:  Hanako Oba; Kazunori Nishida; Shingo Takeuchi; Hirohiko Akiyama; Koji Muramatsu; Masafumi Kurosumi; Toru Kameya
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

3.  Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

Authors:  Antonio García Escudero; Enrique Rodríguez Zarco; Juan Carlos Girón Arjona; María José Ríos Moreno; Katherine Gallardo Rodríguez; Ana Vallejo Benítez; Ricardo González Cámpora
Journal:  Virchows Arch       Date:  2016-06-14       Impact factor: 4.064

Review 4.  Update on large cell neuroendocrine carcinoma.

Authors:  Kenzo Hiroshima; Mari Mino-Kenudson
Journal:  Transl Lung Cancer Res       Date:  2017-10

5.  A Rare Case of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia.

Authors:  Andrea Anampa-Guzmán; Luis E Raez
Journal:  Cureus       Date:  2018-04-24

6.  Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria.

Authors:  Olga Sazonova; Venkata Manem; Chloé Béland; Marc-André Hamel; Yves Lacasse; Marie-Hélène Lévesque; Michèle Orain; David Joubert; Steeve Provencher; David Simonyan; Philippe Joubert
Journal:  JTO Clin Res Rep       Date:  2020-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.